Rabikrad 塩
Ranitidine Hydrochloride 168mg · Tripotassium Bismuth Dicitrate 200mg +1 more
Tablet · Prescription medication · Combination
CMG Pharmaceuticals Co., Ltd.
MFDS item code 201905079 · Approved 2019.07.19
This product's status changed to Expired on 2024.07.19. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of acid-related disorders (e.g., ulcers, gastritis, and reflux esophagitis) and prevention of Mendelson's syndrome
This medication is effective in treating ulcers that occur in the stomach and duodenum, gastritis, and conditions such as Zollinger-Ellison syndrome associated with excessive gastric acid secretion. It is also used in the treatment of gastroesophageal reflux disease and is administered to prevent Mendelson's syndrome during preoperative anesthesia. It helps prevent and treat ulcers that may occur postoperatively and those due to nonsteroidal anti-inflammatory drugs (NSAIDs). This medication protects the gastric mucosa and regulates gastric acid secretion to alleviate symptoms and aid recovery. Therefore, it is widely used for various gastric-related ailments.
Usually, take 1 tablet orally twice daily, in the morning and at bedtime, regardless of meals. 1) Gastric and duodenal ulcers Take 1 tablet twice daily or 2 tablets once daily at bedtime. In particular, a higher cure rate may be achieved in patients with duodenal ulcers by taking 2 tablets twice daily, in the morning and at bedtime. The same dosage applies to combination therapy for ulcers caused by nonsteroidal anti-inflammatory drugs (NSAIDs) or to prevent gastric and duodenal ulcers during long-term NSAID therapy. Diseases caused by NSAID administration usually heal within 4 weeks, and ulcers usually heal within 8 weeks; however, healing time may occasionally be prolonged in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 1 tablet once daily at bedtime as maintenance therapy. 2) Reflux esophagitis For 8 weeks, take 1 tablet twice daily or 2 tablets once daily at bedtime. In patients with severe reflux esophagitis, the dose may be increased to 2 tablets four times daily. 3) Zollinger-Ellison syndrome Start treatment with an initial dose of 1 tablet three times daily and increase the dose as needed. In severe disease, up to 6 g per day of ranitidine may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and take 1 tablet twice daily. 5) Premedication for anesthesia (prevention of Mendelson syndrome) Administer 1 tablet 2 hours before induction of anesthesia. It is also preferable to administer 1 tablet on the night before surgery.
This medication should not be used in patients undergoing dialysis. Patients who have had allergic reactions to this medication or its components should also refrain from taking it. It should not be administered to patients who have previously experienced a rare disease called acute porphyria, as it may worsen symptoms. Patients with poor kidney function or those who have undergone upper gastrointestinal surgery should avoid this medication. It should not be given to pregnant women or those who may become pregnant, nor to premature or newborn infants. Patients on a diet that limits potassium intake should also avoid using this medication. This medication should be used cautiously in patients with compromised liver function, a history of drug allergies, the elderly, or those with a history of kidney issues. Especially for the elderly or those with a history of peptic ulcers taking NSAIDs, regular monitoring is necessary. This medication may mask the symptoms of stomach cancer, so patients with gastric ulcers or middle-aged patients who have newly developed indigestion should confirm that it is not a malignant disease before use. Patients with Helicobacter pylori infections related to gastric or duodenal ulcers must undergo concurrent treatment to eradicate the bacteria. For critically ill patients in intensive care, there is a risk of bezoar formation after administration of this medication, so caution is needed. Patients with hypophosphatemia may experience interference with phosphate absorption due to the aluminum component in this medication. Patients who have difficulty swallowing should be cautious, as respiratory complications may arise after taking this medication. While taking this medication, it is very rare to experience serious allergic reactions such as anaphylactic shock, so if symptoms appear, discontinue use immediately and seek appropriate treatment. Hypersensitivity reactions such as skin rash, hives, angioedema, fever, bronchospasm, hypotension, chest pain may occur, and in such cases, the medication should also be discontinued. Decreased blood cell counts, abnormal liver function, arrhythmias, gastrointestinal symptoms (nausea, vomiting, abdominal pain), and neurological symptoms (dizziness, confusion, seizures) may occur rarely, hence any unusual symptoms should be discussed with a physician. It is important to avoid prolonged use and to monitor treatment progress carefully while using the lowest effective dose. Elderly patients or those with chronic diseases may have an increased risk of pneumonia while taking this medication, thus should be cautioned. If dizziness or drowsiness occurs during use of this medication, it is safest to avoid driving or operating hazardous machinery. There may be interactions with other medications, so if taking any other drugs, it is essential to inform healthcare professionals. It is safe to avoid using this medication for pregnant or nursing women. Safety in children has not been sufficiently established, so it is advisable not to administer it to minors. In case of overdose, emergency treatment such as vomiting or gastric lavage may be necessary, and in some cases, blood dialysis may be beneficial. This medication reduces gastric acid secretion and may promote bacterial proliferation in the gastrointestinal tract, so regular examinations including ophthalmic checks are necessary during prolonged use.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to avoid exposure to air and moisture. Additionally, it should be kept away from extreme heat or cold, and stored at a safe temperature between 1 to 30 degrees Celsius.
Greenish rectangular film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Ranitidine Hydrochloride 168mg · Tripotassium Bismuth Dicitrate 200mg +1 more
Tablet · Prescription medication · Combination
CMG Pharmaceuticals Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Nexpharm Korea Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
HUONS BioScience Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Daewoong Bio Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Teragen Etex Co., Ltd.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Korea Pavise Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Kwangdong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.